Trevi Therapeutics Stock Investor Sentiment
| TRVI Stock | USD 6.81 0.25 3.81% |
Under 58% of all Trevi Therapeutics' traders are looking to take a long position. The analysis of overall sentiment of trading Trevi Therapeutics stock suggests that some investors are interested at this time. Trevi Therapeutics' investing sentiment shows overall attitude of investors towards Trevi Therapeutics.
Trevi |
Trevi Therapeutics Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Trevi Therapeutics can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Far too much social signal, news, headlines, and media speculation about Trevi Therapeutics that are available to investors today. That information is available publicly through Trevi media outlets and privately through word of mouth or via Trevi internal channels. However, regardless of the origin, that massive amount of Trevi data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Trevi Therapeutics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Trevi Therapeutics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Trevi Therapeutics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Trevi Therapeutics alpha.
Trevi Therapeutics Performance against Dow Jones
Price Growth (%) |
| Timeline |
1 | Trevi Therapeutics stock soars to 52-week high of 4.68 - Investing.com | 01/03/2025 |
2 | Disposition of 1000 shares by Lisa Delfini of Trevi Therapeutics at 0.511 subject to Rule 16b-3 | 01/07/2025 |
3 | Disposition of 5000 shares by Lisa Delfini of Trevi Therapeutics at 0.511 subject to Rule 16b-3 | 01/08/2025 |
4 | Trevi Therapeutics, Inc. Sees Significant Decline in Short Interest - MarketBeat | 01/17/2025 |
5 | Acquisition by Christopher Galletta of 41000 shares of Trevi Therapeutics at 4.22 subject to Rule 16b-3 | 02/18/2025 |
6 | Why Trevi Therapeutics Is Advancing Today | 02/20/2025 |
7 | Trevi Therapeutics to Participate in Upcoming March Investor Conferences | 02/27/2025 |
8 | Acquisition by Sciascia Thomas of 12745 shares of Trevi Therapeutics at 1.43 subject to Rule 16b-3 | 03/05/2025 |
9 | Acquisition by Mathers Edward T of 30000 shares of Trevi Therapeutics at 2.77 subject to Rule 16b-3 | 03/07/2025 |
10 | Trevi Therapeutics Announces Positive Topline Results from the Phase 2a RIVER Trial of Haduvio in Patients with Refractory Chronic Cough | 03/10/2025 |
11 | Disposition of 17500 shares by Simon Farrell of Trevi Therapeutics at 3.21 subject to Rule 16b-3 | 03/12/2025 |
12 | Trevi Therapeutics Reports Fourth Quarter and Year End 2024 Financial Results and Provides Business Updates | 03/18/2025 |
Complementary Tools for Trevi Stock analysis
When running Trevi Therapeutics' price analysis, check to measure Trevi Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Trevi Therapeutics is operating at the current time. Most of Trevi Therapeutics' value examination focuses on studying past and present price action to predict the probability of Trevi Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Trevi Therapeutics' price. Additionally, you may evaluate how the addition of Trevi Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |